The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma.

Case Rep Hematol · 2019 · PMC6757244 · PMID 31612086

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Furthermore, as recently observed in large multicenter randomized trials, a positive trend favoring lenalidomide plus R-CHOP versus R-CHOP alone was observed in previously untreated high-risk DLBCL [ 16 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.